Revolutionizing the Audit Process: Advancements in Supplier Assessments Within the Pharmaceutical Sector

Pharmaceutical companies invest significant resources in research and development to discover new drugs and therapies and improve existing ones. This involves rigorous testing, clinical trials, and obtaining regulatory approval before a drug can be sold.

Government agencies, such as the Food and Drug Administration (FDA) in the United States, oversee the approval process and conduct regular inspections of manufacturing facilities to ensure compliance with regulations.

But what are some of the most significant challenges facing the pharmaceutical industry today, and how are companies addressing them?

On today’s episode of the Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Jim Fries, the Chief Executive Officer of Rx-360, to discuss some of the key benefits of using supplier evaluations and how they can help pharmaceutical companies to ensure supply chain integrity and compliance with regulations.

Jim Fries’ core piece of advice: prioritize compliance and quality in all aspects of the pharmaceutical manufacturing process. This includes investing in robust quality systems, conducting regular audits, and seeking licensable audit reports from independent third-party auditors. By doing so, manufacturers can ensure that their products are safe and effective and meet regulatory requirements.

“We have the ability as a non-profit to license a report out to other pharmaceutical organizations in the industry that may be using that same supplier and try to double-check authenticity,” said Fries.

Michelle and Jim also discuss…

  1. What are the benefits and steps in obtaining a licensable audit report for pharmaceutical manufacturers, and how does it aid in regulatory compliance and product quality assurance?
  2. In what ways does Rx-360’s collaboration with Benchmark Products enhance supply chain security and quality within the pharmaceutical industry?
  3. How can pharmaceutical manufacturers leverage licensable audit reports to gain a competitive advantage in the industry and improve patient outcomes?

“It’s a wonderful way for pharmaceutical organizations to license with their supplier to ensure that safety and quality information on that particular facility is distributed amongst the pharmaceutical community where we are also actively collaborating,” said Fries.

James M. Fries, CEO at Rx-360, has worked with teams at OrthoForge, VNUS Medical, Vascular Insights, etc. He received his B.A. in Organizational Behavior and his MBA from Eastern University in St. David’s, PA.

Follow us on social media for the latest updates in B2B!


home valuation
Zillow’s Not a Real Estate Agent. Don’t Rely On It To Find Your Home Valuation
June 1, 2023

In the dynamic landscape of real estate, home valuation is a delicate process requiring not just data, but a deep understanding of unique property features and market trends. Platforms like Zillow offer a numerical estimate based on comps or square footage but can fail to capture the essence of a home, from interior renovations […]

Read More
housing market
Can You Find Your Home Sweet Home in This Unpredictable Housing Market?
June 1, 2023

In the fluctuating landscape of the current unpredictable housing market, potential homebuyers are navigating high mortgage rates, volatile economic conditions, housing changes and a tightening inventory. Home prices have shown a slight decline with the median existing-home sales price dropping 0.9% to $375,700 in March compared to a year ago. It’s the second month […]

Read More
Affordable Care Act
Legal Battles and Uncertainty Surrounding Affordable Care Act’s Preventative Services Coverage
June 1, 2023

The Affordable Care Act (ACA) has faced numerous legal challenges since its inception, leaving its future uncertain.  Texas’s courts recently overturned insurance provider coverage requirements for certain preventative health services, altering the landscape of coverage. However, a higher court has now blocked that overturning order, reinstating insurers’ obligation to cover those services. While not all […]

Read More